Avocatin B: Its Role in Cancer and Diabetes Mellitus Treatment

Aslı Melike Ekmekçi,Arzu Kasabalı, Oytun Erbaş

DOI: 10.5606/jebms.2023.1039

Issue: 2023, Volume 4 - Issue 1
2565 1658

The Metabolic Syndrome: A Cancer Risk Factor?

Ayça Nur Demir, Kerem Can Tunç, Mehtap Odabaşı, Oytun Erbaş

DOI: 10.5606/jebms.2023.1040

Issue: 2023, Volume 4 - Issue 1
787 658

Emerging Immunotherapeutic Approaches for Managing Metastasis

Alper Demirezen, Oytun Erbaş

DOI: 10.5606/jebms.2023.1050

Issue: 2023, Volume 4 - Issue 2
707 568

Regulatory T Cells and Their Implications in Cancer Immunotherapy

Saime Sıla Gemici, Oytun Erbaş

DOI: 10.5606/jebms.2023.1064

Issue: 2023, Volume 4 - Issue 3
480 483

Cancer Stem Cells

Alper Demirezen, Oytun Erbaş

DOI: 10.5606/jebms.2024.1083

Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
600 425

Stem Cell Therapy in Cancer

Ayça Nur Demir, Oytun Erbaş

DOI: 10.5606/jebms.2024.1084

Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
507 410

Enteral Nutrition in Cancer Patients

Gamze Nur Yüksel, Oytun Erbaş

DOI: 10.5606/jebms.2024.1089

Issue: 2024, Volume 5 - Issue 2
454 529

Coffee Intake and Cancer Risk: Exploring the Relationship

Zehra Betül Aydın, Oytun Erbaş

DOI: 10.5606/jebms.2024.1091

Issue: 2024, Volume 5 - Issue 2
477 527

Aspirin and NSAIDs as Cancer Preventive Agents: A Review

Nadin Bedikyan, Oytun Erbaş

DOI: 10.5606/jebms.2024.1093

Issue: 2024, Volume 5 - Issue 2
461 541

HERG1 and Cancer: Exploring the Nexus Between Ion Channels and Tumorigenesis

Alper Demirezen, Oytun Erbaş

DOI: 10.5606/jebms.2024.1100

Issue: 2024, Volume 5 - Issue 4
203 215

The Role of STAT3 in Cancer Development and Progression

Gökçen Kılınç, Oytun Erbaş

DOI: 10.5606/jebms.2024.1101

Issue: 2024, Volume 5 - Issue 4
166 230

Histone Deacetylase Inhibitors in Cancer Treatment

Şule Demirkasaoğlu, Oytun Erbaş

DOI: 10.5606/jebms.2024.1102

Issue: 2024, Volume 5 - Issue 4
188 208